Kunal Ray
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kunal Ray has a total of 441 co-authors. Here are the top co-authors by number of shared publications:
- Mainak Sengupta
Department of Genetics, University of Calcutta, Kolkata, India.
29 shared publications - Arijit Mukhopadhyay
Translational Medicine Laboratory, Biomedical Research and Innovation Centre, University of Salford, Manchester M5 4WT, UK
24 shared publications Moumita Chaki
Molecular and Human Genetics Division, Indian Institute of Chemical Biology (a Unit of CSIR), Kolkata, India
21 shared publicationsAbhijit Sen
Drishti Pradip, Kolkata 700068, India
13 shared publicationsMoulinath Acharya
Molecular & Human Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India
13 shared publicationsArnab Gupta
12 shared publications
Latest Publications
- Open Access
- 13 March 2025
- Published by AccScience Publishing in Gene & Protein in Disease
- Vol. 4 (2) , 7503
Identifying regulatory variants in Indian Wilson’s disease patients with missing heritability
Wilson’s disease (WD) is a rare autosomal recessive copper metabolism disorder that primarily affects hepatic and neuronal tissues. The condition is caused by mutations in the ATP7B gene. Our group conducted extensive molecular genetic studies, identifying 13 clinically diagnosed Indian WD patients lacking the coding variant of ATP7B and 17 patients with a single mutated allele. We hypothesize that in these patients, unidentified mutations may reside in cis-regulatory elements of ATP7B or that a WD-like phenotype results from the cumulative effect of hypofunctional alleles of other key genes in the copper metabolism pathway. In this study, we employed an established bioinformatic pipeline to identify and screen cis-regulatory elements of ATP7B in WD patients with missing heritability through polymerase chain reaction sequencing. Although no pathogenic variants were identified, our analysis revealed two heterozygous single nucleotide polymorphisms (rs2181891 and rs747781) in two patients. Notably, rs2181891 showed strong regulatory potential with a RegulomeDB score of 1d. The genotype-specific expression profile for rs2181891 revealed it to be an expression quantitative trait locus for ATP7B in the cerebellum. In addition, the Genotype-Tissue Expression portal data suggest that the T allele of rs2181891 is associated with higher expression of ATP7B, making it unlikely to contribute to the WD phenotype. This novel study is the first to identify and screen ATP7B cis-regulatory elements in Indian WD patients with missing heritability.
- 13 March 2025
- Published by AccScience Publishing in Gene & Protein in Disease
- Vol. 4 (2) , 7503
Open AccessIdentifying regulatory variants in Indian Wilson’s disease patients with missing heritability
Wilson’s disease (WD) is a rare autosomal recessive copper metabolism disorder that primarily affects hepatic and neuronal tissues. The condition is caused by mutations in the ATP7B gene. Our group conducted extensive molecular genetic studies, identifying 13 clinically diagnosed Indian WD patients lacking the coding variant of ATP7B and 17 patients with a single mutated allele. We hypothesize that in these patients, unidentified mutations may reside in cis-regulatory elements of ATP7B or that a WD-like phenotype results from the cumulative effect of hypofunctional alleles of other key genes in the copper metabolism pathway. In this study, we employed an established bioinformatic pipeline to identify and screen cis-regulatory elements of ATP7B in WD patients with missing heritability through polymerase chain reaction sequencing. Although no pathogenic variants were identified, our analysis revealed two heterozygous single nucleotide polymorphisms (rs2181891 and rs747781) in two patients. Notably, rs2181891 showed strong regulatory potential with a RegulomeDB score of 1d. The genotype-specific expression profile for rs2181891 revealed it to be an expression quantitative trait locus for ATP7B in the cerebellum. In addition, the Genotype-Tissue Expression portal data suggest that the T allele of rs2181891 is associated with higher expression of ATP7B, making it unlikely to contribute to the WD phenotype. This novel study is the first to identify and screen ATP7B cis-regulatory elements in Indian WD patients with missing heritability.
- Open Access
- 26 September 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102222
Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view
- 26 September 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102222
Open AccessTime to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view
- Open Access
Whole Exome Sequencing Reveals Novel Candidate Genes in Familial Forms of Glaucomatous Neurodegeneration
Glaucoma is the largest cause of irreversible blindness with a multifactorial genetic etiology. This study explores novel genes and gene networks in familial forms of primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) to identify rare mutations with high penetrance. Thirty-one samples from nine MYOC-negative families (five POAG and four PACG) underwent whole-exome sequencing and analysis. A set of prioritized genes and variations were screened in an independent validation cohort of 1536 samples and the whole-exome data from 20 sporadic patients. The expression profiles of the candidate genes were analyzed in 17 publicly available expression datasets from ocular tissues and single cells. Rare, deleterious SNVs in AQP5, SRFBP1, CDH6 and FOXM1 from POAG families and in ACACB, RGL3 and LAMA2 from PACG families were found exclusively in glaucoma cases. AQP5, SRFBP1 and CDH6 also revealed significant altered expression in glaucoma in expression datasets. Single-cell expression analysis revealed enrichment of identified candidate genes in retinal ganglion cells and corneal epithelial cells in POAG; whereas for PACG families, retinal ganglion cells and Schwalbe’s Line showed enriched expression. Through an unbiased exome-wide search followed by validation, we identified novel candidate genes for familial cases of POAG and PACG. The SRFBP1 gene found in a POAG family is located within the GLC1M locus on Chr5q. Pathway analysis of candidate genes revealed enrichment of extracellular matrix organization in both POAG and PACG.
Open AccessWhole Exome Sequencing Reveals Novel Candidate Genes in Familial Forms of Glaucomatous Neurodegeneration
Glaucoma is the largest cause of irreversible blindness with a multifactorial genetic etiology. This study explores novel genes and gene networks in familial forms of primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) to identify rare mutations with high penetrance. Thirty-one samples from nine MYOC-negative families (five POAG and four PACG) underwent whole-exome sequencing and analysis. A set of prioritized genes and variations were screened in an independent validation cohort of 1536 samples and the whole-exome data from 20 sporadic patients. The expression profiles of the candidate genes were analyzed in 17 publicly available expression datasets from ocular tissues and single cells. Rare, deleterious SNVs in AQP5, SRFBP1, CDH6 and FOXM1 from POAG families and in ACACB, RGL3 and LAMA2 from PACG families were found exclusively in glaucoma cases. AQP5, SRFBP1 and CDH6 also revealed significant altered expression in glaucoma in expression datasets. Single-cell expression analysis revealed enrichment of identified candidate genes in retinal ganglion cells and corneal epithelial cells in POAG; whereas for PACG families, retinal ganglion cells and Schwalbe’s Line showed enriched expression. Through an unbiased exome-wide search followed by validation, we identified novel candidate genes for familial cases of POAG and PACG. The SRFBP1 gene found in a POAG family is located within the GLC1M locus on Chr5q. Pathway analysis of candidate genes revealed enrichment of extracellular matrix organization in both POAG and PACG.
- 3 December 2022
- Published by Springer Nature in Mammalian Genome
- Vol. 34 (1) , 1-11
Missing heritability of Wilson disease: a search for the uncharacterized mutations
Wilson disease (WD), a copper metabolism disorder caused by mutations in ATP7B, manifests heterogeneous clinical features. Interestingly, in a fraction of clinically diagnosed WD patients, mutations in ATP7B appears to be missing. In this review we discuss the plausible explanations of this missing heritability and propose a workflow that can identify the hidden mutations. Mutation analyses of WD generally includes targeted sequencing of ATP7B exons, exon–intron boundaries, and rarely, the proximal promoter region. We propose that variants in the distal cis-regulatory elements and/or deep intronic variants that impact splicing might well represent the hidden mutations. Heterozygous del/ins that remain refractory to conventional PCR-sequencing method may also represent such mutations. In this review, we also hypothesize that mutations in the key copper metabolism genes, like, ATOX1, COMMD1, and SLC31A1, could possibly lead to a WD-like phenotype. In fact, WD does present overlapping symptoms with other rare genetic disorders; hence, the possibility of a misdiagnosis and thus adding to missing heritability cannot be excluded. In this regard, it seems that whole-genome analysis will provide a comprehensive and rapid molecular diagnosis of WD. However, considering the associated cost for such a strategy, we propose an alternative customized screening schema of WD which include targeted sequencing of ATP7B locus as well as other key copper metabolism genes. Success of such a schema has been tested in a pilot study.
- 3 December 2022
- Published by Springer Nature in Mammalian Genome
- Vol. 34 (1) , 1-11
Missing heritability of Wilson disease: a search for the uncharacterized mutations
Wilson disease (WD), a copper metabolism disorder caused by mutations in ATP7B, manifests heterogeneous clinical features. Interestingly, in a fraction of clinically diagnosed WD patients, mutations in ATP7B appears to be missing. In this review we discuss the plausible explanations of this missing heritability and propose a workflow that can identify the hidden mutations. Mutation analyses of WD generally includes targeted sequencing of ATP7B exons, exon–intron boundaries, and rarely, the proximal promoter region. We propose that variants in the distal cis-regulatory elements and/or deep intronic variants that impact splicing might well represent the hidden mutations. Heterozygous del/ins that remain refractory to conventional PCR-sequencing method may also represent such mutations. In this review, we also hypothesize that mutations in the key copper metabolism genes, like, ATOX1, COMMD1, and SLC31A1, could possibly lead to a WD-like phenotype. In fact, WD does present overlapping symptoms with other rare genetic disorders; hence, the possibility of a misdiagnosis and thus adding to missing heritability cannot be excluded. In this regard, it seems that whole-genome analysis will provide a comprehensive and rapid molecular diagnosis of WD. However, considering the associated cost for such a strategy, we propose an alternative customized screening schema of WD which include targeted sequencing of ATP7B locus as well as other key copper metabolism genes. Success of such a schema has been tested in a pilot study.
- 13 July 2020
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 71 (2) , 325-337
Association of TOR1A and GCH1 Polymorphisms with Isolated Dystonia in India
Isolated dystonia is a common movement disorder often caused by genetic mutations, although it is predominantly sporadic in nature. Common variants of dystonia-related genes were reported to be risk factors for idiopathic isolated dystonia. In this study, we aimed to analyse the roles of previously reported GTP cyclohydrolase (GCH1) and Torsin family 1 member A (TOR1A) polymorphisms in an Indian isolated dystonia case-control group. A total of 292 sporadic isolated dystonia patients and 316 control individuals were genotyped for single-nucleotide polymorphisms (SNPs) of GCH1 (rs3759664:G > A, rs12147422:A > G and rs10483639:C > G) and TOR1A (rs13300897:G > A, rs1801968:G > C, rs1182:G > T and rs3842225:G > Δ) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and confirmed by direct Sanger sequencing. The statistical significance of allelic, genotypic and haplotypic associations of all of the SNPs were evaluated using the two-tailed Fisher exact test. The minor allele (A) of rs3759664 is significantly associated with isolated limb dystonia as a risk factor (p = 0.005). The minor allele (C) of rs1801968 is strongly associated with isolated dystonia (p < 0.0001) and most of its subtypes. The major allele of rs3842225 (G) may act as a significant risk factor for Writer’s cramp (p = 0.03). Four different haplogroups comprising of either rs1182 or rs3842225 or in combination with rs1801968 and rs13300897 were found to be significantly associated with isolated dystonia. No other allelic, genotypic or haplotypic association was found to be significant with isolated dystonia cohort or its endophenotype stratified groups. Our study suggests that TOR1A common variants have a significant role in isolated dystonia pathogenesis in the Indian population, whereas SNPs in the GCH1 gene may have a limited role.
- 13 July 2020
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 71 (2) , 325-337
Association of TOR1A and GCH1 Polymorphisms with Isolated Dystonia in India
Isolated dystonia is a common movement disorder often caused by genetic mutations, although it is predominantly sporadic in nature. Common variants of dystonia-related genes were reported to be risk factors for idiopathic isolated dystonia. In this study, we aimed to analyse the roles of previously reported GTP cyclohydrolase (GCH1) and Torsin family 1 member A (TOR1A) polymorphisms in an Indian isolated dystonia case-control group. A total of 292 sporadic isolated dystonia patients and 316 control individuals were genotyped for single-nucleotide polymorphisms (SNPs) of GCH1 (rs3759664:G > A, rs12147422:A > G and rs10483639:C > G) and TOR1A (rs13300897:G > A, rs1801968:G > C, rs1182:G > T and rs3842225:G > Δ) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and confirmed by direct Sanger sequencing. The statistical significance of allelic, genotypic and haplotypic associations of all of the SNPs were evaluated using the two-tailed Fisher exact test. The minor allele (A) of rs3759664 is significantly associated with isolated limb dystonia as a risk factor (p = 0.005). The minor allele (C) of rs1801968 is strongly associated with isolated dystonia (p < 0.0001) and most of its subtypes. The major allele of rs3842225 (G) may act as a significant risk factor for Writer’s cramp (p = 0.03). Four different haplogroups comprising of either rs1182 or rs3842225 or in combination with rs1801968 and rs13300897 were found to be significantly associated with isolated dystonia. No other allelic, genotypic or haplotypic association was found to be significant with isolated dystonia cohort or its endophenotype stratified groups. Our study suggests that TOR1A common variants have a significant role in isolated dystonia pathogenesis in the Indian population, whereas SNPs in the GCH1 gene may have a limited role.
- 2 March 2020
- Published by Wiley in Annals of Human Genetics
- Vol. 84 (3) , 303-312
Mapping the TYR gene reveals novel and previously reported variants in Eastern Indian patients highlighting preponderance of the same changes in multiple unrelated ethnicities
Oculocutaneous albinism (OCA) is a group of congenital autosomal recessive disorders with seven known subtypes (OCA1–OCA7) characterized by loss or absence of pigmentation in the skin, hair, and eyes. OCA1, caused by pathogenic variations in the tyrosinase (TYR) gene, has been documented to be the most prevalent subtype across the world including India. In the present study, we recruited 53 OCA‐affected individuals from 45 unrelated families belonging to 20 different marriage groups/ethnicities of 15 different districts of West Bengal. We took a targeted sequencing‐based approach to find the causal variations in the TYR gene. We report here identification of two novel potentially pathogenic variations [NM_000372.4:c.614C>T, NP_000363.1:p.(Pro205Leu), and NM_000372.4:c.1036+1=/G>T], one novel synonymous TYR variant [NM_000372.4:c.204=/A>G, NP_000363.1:p.(Gln68=)], two pathogenic variations documented for the first time in Indian OCA cases [NM_000372.4:c.1147G>A, NP_000363.1:p.(Asp383Asn), and NM_000372.4:c.585G>A, NP_000363.1:p.(Trp195*)], along with nine previously reported pathogenic variants in 36 out of 53 (∼68%) patients recruited. We report common haplotype backgrounds for the two most prevalent variations [NM_000372.4:c.124G>A, NM_000372.4:c.832C>T] in cases belonging to different marriage/ethnic groups, suggesting a possible founder effect. To our knowledge, this is the most comprehensive genetic study on OCA1 from India, firmly establishing OCA1 as the commonest form of albinism in this part of the world.
- 2 March 2020
- Published by Wiley in Annals of Human Genetics
- Vol. 84 (3) , 303-312
Mapping the TYR gene reveals novel and previously reported variants in Eastern Indian patients highlighting preponderance of the same changes in multiple unrelated ethnicities
Oculocutaneous albinism (OCA) is a group of congenital autosomal recessive disorders with seven known subtypes (OCA1–OCA7) characterized by loss or absence of pigmentation in the skin, hair, and eyes. OCA1, caused by pathogenic variations in the tyrosinase (TYR) gene, has been documented to be the most prevalent subtype across the world including India. In the present study, we recruited 53 OCA‐affected individuals from 45 unrelated families belonging to 20 different marriage groups/ethnicities of 15 different districts of West Bengal. We took a targeted sequencing‐based approach to find the causal variations in the TYR gene. We report here identification of two novel potentially pathogenic variations [NM_000372.4:c.614C>T, NP_000363.1:p.(Pro205Leu), and NM_000372.4:c.1036+1=/G>T], one novel synonymous TYR variant [NM_000372.4:c.204=/A>G, NP_000363.1:p.(Gln68=)], two pathogenic variations documented for the first time in Indian OCA cases [NM_000372.4:c.1147G>A, NP_000363.1:p.(Asp383Asn), and NM_000372.4:c.585G>A, NP_000363.1:p.(Trp195*)], along with nine previously reported pathogenic variants in 36 out of 53 (∼68%) patients recruited. We report common haplotype backgrounds for the two most prevalent variations [NM_000372.4:c.124G>A, NM_000372.4:c.832C>T] in cases belonging to different marriage/ethnic groups, suggesting a possible founder effect. To our knowledge, this is the most comprehensive genetic study on OCA1 from India, firmly establishing OCA1 as the commonest form of albinism in this part of the world.
- 1 June 2018
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 1
LMDRA (leucine rich melanocyte differentiation associated)
- 1 June 2018
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 1
LMDRA (leucine rich melanocyte differentiation associated)
- 1 June 2018
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 1
TYRP1 (tyrosinase-related protein 1)
- 1 June 2018
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 1
TYRP1 (tyrosinase-related protein 1)
- Open Access
- 1 January 2018
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 10 (3) , 378-387
A glimpse into the regulation of the Wilson disease protein, ATP7B, sheds light on the complexity of mammalian apical trafficking pathways
Wilson disease (WD), a Mendelian disorder of copper metabolism caused by mutations in theATP7Bgene, manifests a large spectrum of phenotypic variability.
- 1 January 2018
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 10 (3) , 378-387
Open AccessA glimpse into the regulation of the Wilson disease protein, ATP7B, sheds light on the complexity of mammalian apical trafficking pathways
Wilson disease (WD), a Mendelian disorder of copper metabolism caused by mutations in theATP7Bgene, manifests a large spectrum of phenotypic variability.